Pakistan

Oxford Economics Study Reveals Haleon Pakistan’s Role in Supporting Pakistan’s Economy and Healthcare Access

At a high-level event hosted at the British High Commission in Islamabad, a local subsidiary of a leading British consumer healthcare company, Haleon Pakistan Limited officially launched its 2024 Economic Impact Study, conducted by Oxford Economics. The study provides compelling insight into Haleon’s deep and multifaceted contribution to Pakistan’s economy, healthcare sector, and local value chains.

The event brought together key government representatives, diplomats, economists and industry leaders for a timely conversation on how purpose-led investment can advance inclusive growth, strengthen local supply chains, and improve healthcare access across the country.

Ad Powered By Advergic
Loading ad . . .
Ad - Continue scrolling to read

In his keynote remarks, Federal Minister for Investment, Qaiser Ahmed Sheikh positioned the findings within Pakistan’s broader macroeconomic agenda: “Pakistan is open for business. We look to investors who share our commitment to long-term sustainability, knowledge-sharing, capacity-building and social progress. This report shows that such investors already exist among us. We encourage others to follow this model, to go beyond transactions and invest in transformation. I thank Haleon for its continued partnership with Pakistan, and Oxford Economics for conducting this robust and transparent study.”

British High Commissioner to Pakistan, H.E. Jane Marriott, reinforced the value of cross-border partnerships: “Haleon’s presence in Pakistan is a strong example of how British businesses are going beyond commerce by investing in communities, strengthening local manufacturing, and supporting national supply chains. The UK remains committed to deepening trade and investment ties with Pakistan, especially in sectors that promote resilience, inclusivity, and innovation.”

Commissioned by Haleon Pakistan Limited, a local subsidiary of a British multinational with leading brands such as Panadol, Sensodyne and Centrum, and conducted by Oxford Economics, one of the world’s most respected independent advisory firms, the study quantifies Haleon Pakistan’s economic footprint across three dimensions: direct operations, domestic supply chains and induced economic activity via employee spending.

In 2024 alone, Haleon Pakistan’s total contribution to GDP was US$ 98 million (Rs. 27 billion) and supported 6,600 jobs nationwide. The study noted that Haleon Pakistan supports high-productivity employment, partners with domestic manufacturers and suppliers and contributes to local industrial capability while ensuring wide-reaching healthcare access.

A panel discussion followed, themed “Investing with Purpose in Pakistan,” featuring Federal Minister for Investment Qaiser Ahmed Sheikh, Senior Research Economist Ms. Afia Malik and Haleon Pakistan’s CEO and GM Qawi Naseer.

[IMAGE INSERT]

Haleon’s operations span offices in Karachi, Lahore, Multan, Islamabad and a manufacturing plant in Jamshoro. The company’s investment in domestic procurement, including contract manufacturing, signals its long-term commitment to Pakistan’s industrial base.

CEO Qawi Naseer emphasized that Haleon Pakistan’s goals extend beyond market leadership: “The study findings from Oxford Economics affirm our belief that business performance must go hand-in-hand with national value creation. “We are proud to support Pakistan’s economy, through healthcare access and high-impact employment, local procurement and long-term partnerships across the value chain.”

While the study does quantify Haleon’s contributions in GDP and employment, it also highlights the company’s indirect impact on adjacent sectors such as manufacturing, agriculture, and retail, underscoring how one firm’s commitment can catalyse broader socio-economic resilience.

Share
Published by
Press Release